The uveitis–glaucoma–hyphema syndrome. Part 2. Comparative analysis of existing treatment methods effectiveness

Abstract

Background: The uveitis–glaucoma–hyphema syndrome is a disease caused by iris injury due to extracapsular fixation of intraocular lens (IOL). ES Treatment involves IOL fixation or exchange.

Aim: To compare the effectiveness of various surgical methods of uveitis–glaucoma–hyphema syndrome treatment.

Materials and methods: The study group included 95 patients (95 eyes), divided into six subgroups depending on surgical treatment methods used: hydrophobic IOL exchange on hydrophilic model (HYDRO) with its transscleral fixation (n = 20); transscleral fixation (TSF) of native IOL (n = 18); hydrophobic IOL exchange on polymethylmethacrylate iris-claw IOL (CLAW; n = 22); iris-fixated IOLs (IRIS; n = 8); IOL immobilization with scleral bandage sutures (BS; n = 4); conservative treatment (CT; n = 23). The methods were compared using a scoring system.

Results: The final score of surgical methods effectiveness is presented in descending order: HYDRO — 5.36 ± 1.05, TSF — 5.21 ± 1.80, CLAW — 3.87 ± 3.34, IRIS — 1.26 ± 4.41, BS — –0.74 ± 3.66, CL — –3.26 ± 2.51 (p < 0.001).

CONCLUSIONS: Uveitis–glaucoma–hyphema syndrome surgical management is a complex problem due to necessity of several interventions performing directed to eliminate the cause factor of recurrent hemorrhages — mechanical traumatization of iris by IOL. The comparison of various surgical techniques demonstrated the greatest effectiveness of HYDRO, TSF, and CLAW. Suture fixation of the IOL to the iris showed slightly less effectiveness. Using of bandage sutures for UGH treatment is inappropriate due to the high risk of relapse.

Keywords

phacoemulsification / intraocular lens / complication / Ellingson syndrome / uveitis–glaucoma–hyphema syndrome / transscleral suture fixation / iris-claw IOL

References

[1] Badakere SV, Senthil S, Turaga K, Garg P. Uveitis–glaucoma–hyphaema syndrome with in-the-bag placement of intraocular lens. BMJ Case Rep. 2016;2016: bcr2015213745. doi: 10.1136/bcr-2015-213745

[2] Badakere S.V., Senthil S., Turaga K., Garg P. Uveitis–glaucoma–hyphaema syndrome with in-the-bag placement of intraocular lens // BMJ Case Rep. 2016. Vol. 2016. P. bcr2015213745. doi: 10.1136/bcr-2015-213745

[3] Shi J, Han JV, McGhee CNJ, Zhang J. Vision threatening uveitis–glaucoma–hyphaema syndrome: An uncommon but continuing concern in the 21st century. Clin Exp Ophthalmol. 2020;48(1):127–130. doi: 10.1111/ceo.13655

[4] Shi J., Han J.V., McGhee C.N.J., Zhang J. Vision threatening uveitis–glaucoma–hyphaema syndrome: An uncommon but continuing concern in the 21st century // Clin Exp Ophthalmol. 2020. Vol. 48, N 1. P. 127–130. doi: 10.1111/ceo.13655

[5] Apple DJ, Mamalis N, Loftfield K, et al. Complications of intraocular lenses. A historical and histopathological review. Surv Ophthalmol. 1984;29(1):1–54. doi: 10.1016/0039-6257(84)90113

[6] Apple D.J., Mamalis N., Loftfield K., et al. Complications of intraocular lenses. A historical and histopathological review // Surv Ophthalmol. 1984. Vol. 29, N 1. P. 1–54. doi: 10.1016/0039-6257(84)90113

[7] Zhang L, Hood CT, Vrabec JP, et al. Mechanisms for in-the-bag uveitis–glaucoma–hyphema syndrome. J Cataract Refract Surg. 2014;40(3):490–492. doi: 10.1016/j.jcrs.2013.12.002

[8] Zhang L., Hood C.T., Vrabec J.P., et al. Mechanisms for in-the-bag uveitis–glaucoma–hyphema syndrome // J Cataract Refract Surg. 2014. Vol. 40, N 3. P. 490–492. doi: 10.1016/j.jcrs.2013.12.002

[9] Durr GM, Ahmed IIK. Intraocular lens complications: decentration, uveitis–glaucoma–hyphema syndrome, opacification, and refractive surprises. Ophthalmology. 2021;128(11):e186–e194. doi: 10.1016/j.ophtha.2020.07.004

[10] Durr G.M., Ahmed I.I.K. Intraocular lens complications: decentration, uveitis–glaucoma–hyphema syndrome, opacification, and refractive surprises // Ophthalmology. 2021. Vol. 128, N 11. P. e186–e194. doi: 10.1016/j.ophtha.2020.07.004

[11] Duchêne M, Iscar C, Muraine M, Gueudry J. Characteristics and management of Uveitis–Glaucoma–Hyphema syndrome. J Fr Ophtalmol. 2020;43(3):205–210. (In French.) doi: 10.1016/j.jfo.2019.07.030

[12] Duchêne M., Iscar C., Muraine M., Gueudry J. Caractéristiques et prise en charge du syndrome Uvéite–Glaucome–Hyphéma // J Fr Ophtalmol. 2020. Vol. 43, N 3. P. 205–210. doi: 10.1016/j.jfo.2019.07.030

[13] Elhusseiny AM, Lee RK, Smiddy WE. Surgical management of uveitis–glaucoma–hyphema syndrome. Int J Ophthalmol. 2020;13(6):935–940. doi: 10.18240/ijo.2020.06.12

[14] Elhusseiny A.M., Lee R.K., Smiddy W.E. Surgical management of uveitis–glaucoma–hyphema syndrome // Int J Ophthalmol. 2020. Vol. 13, N 6. P. 935–940. doi: 10.18240/ijo.2020.06.12

[15] Antonova AV, Nikolaenko VP, Brzheskiy VV, Vuks AJa. Factors influencing the effectiveness of trabeculectomy: following materials of the City Multidisciplinary Hospital. Ophthalmology Reports. 2022;15(4):3544. EDN: TRIJLV doi: 10.17816/OV159363

[16] Антонова А.В., Николаенко В.П., Бржеский В.В., Вукс А.Я. Факторы, снижающие эффективность синустрабекулэктомии: по материалам Санкт-Петербургского городского офтальмологического центра // Офтальмологические ведомости. 2022. Т. 15, № 4. С. 35–44. EDN: TRIJLV doi: 10.17816/OV159363

[17] Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968;66(4):673–679.

[18] Cairns J.E. Trabeculectomy. Preliminary report of a new method // Am J Ophthalmol. 1968. Vol. 66, N 4. P. 673–679.

[19] Nikolaenko VP, Brzheskiy VV, Аntonova АV. The extension of indications for the implantation of Ahmed valve. Ophthalmology Reports. 2023;16(2):83–90. EDN: LUYUYY doi: 10.17816/OV340821

[20] Николаенко В.П., Бржеский В.В., Антонова А.В. Расширение показаний к имплантации клапана Ахмеда // Офтальмологические ведомости. 2023. Т. 16, № 2. C. 83–90. EDN: LUYUYY doi: 10.17816/OV340821

[21] Liu Z, Zhang F, Wen Y et al. Diode laser transscleral cyclophotocoagulation for uveitis–glaucoma–hyphema syndrome: A case report. Medicine (Baltimore). 2020;99(7):e18637. doi: 10.1097/MD.0000000000018637

[22] Liu Z., Zhang F., Wen Y., et al. Diode laser transscleral cyclophotocoagulation for uveitis–glaucoma–hyphema syndrome: A case report // Medicine (Baltimore). 2020. Vol. 99, N 7. P. e18637. doi: 10.1097/MD.0000000000018637

[23] Walland MJ. Uveitis–glaucoma–hyphaema (UGH) syndrome treated with local laser iridoplasty. Clin Exp Ophthalmol. 2017;45(6):647–648. doi: 10.1111/ceo.12928

[24] Walland M.J. Uveitis–glaucoma–hyphaema (UGH) syndrome treated with local laser iridoplasty // Clin Exp Ophthalmol. 2017. Vol. 45, N 6. P. 647–648. doi: 10.1111/ceo.12928

[25] Kozhukhov AA, Kapranov DO, Kazakova MV. Our practice of fixing a posterior chamber IOL after phacoemulsification of the cataract complicated by damaged lens capsule support. Clinical cases. Russian Ophthalmological Journal. 2018;11(2):54–57. EDN: XOTJLF doi: 10.21516/2072-0076-2018-11-2-54-57

[26] Кожухов А.А., Капранов Д.О., Казакова М.В. Наш опыт фиксации заднекамерной ИОЛ после факоэмульсификации катаракты, осложненной нарушением капсульной поддержки хрусталика. Клинические случаи // Российский офтальмологический журнал. 2018. Т. 11, № 2. С. 54–57. EDN: XOTJLF doi: 10.21516/2072-0076-2018-11-2-54-57

[27] Potemkin VV, Goltsman EV, Yarovoy DA, Wang SYu. Scleral IOL fixation using limbal mini-pockets: description of the method and clinical cases. Ophthalmology Reports. 2019;12(2)85–90. EDN: FOBRZD doi: 10.17816/OV12285-90

[28] Потёмкин В.В., Гольцман Е.В., Яровой Д.А., Ван С.Ю. Новый метод транссклеральной фиксации интраокулярных линз при помощи лимбальных мини-карманов: описание методики и клинические случаи // Офтальмологические ведомости. 2019. Т. 12, № 2. P. 85–90. EDN: FOBRZD doi: 10.17816/OV12285-90

[29] McCannel MA. A retrievable suture idea for anterior uveal problems. Ophthalmic Sur. 1976;7(2):98–103.

[30] McCannel M.A. A retrievable suture idea for anterior uveal problems // Ophthalmic Sur. 1976. Vol. 7, N 2. P. 98–103.

[31] Condon GP, Masket S, Kranemann C, et al. Small-incision iris fixation of foldable intraocular lenses in the absence of capsule support. Ophthalmology. 2007;114(7):1311–1318. doi: 10.1016/j.ophtha.2007.04.018

[32] Condon G.P., Masket S., Kranemann C., et al. Small-incision iris fixation of foldable intraocular lenses in the absence of capsule support // Ophthalmology. 2007. Vol. 114, N 7. P. 1311–1318. doi: 10.1016/j.ophtha.2007.04.018

[33] Potemkin VV, Astakhov SY, Varganova S, et al. Long-term results of late “in-the-bag” IOL dislocation surgery. Ophthalmology Reports. 2023;16(2)17–27. EDN: WUGKPD doi: 10.17816/OV321819

[34] Потемкин В.В., Астахов С.Ю., Варганова С. и др. Оценка отдалённых результатов хирургического лечения поздней дислокации комплекса «интраокулярная линза – капсульный мешок» // Офтальмологические ведомости. 2023. Т. 16, № 2. С. 17–27. EDN: WUGKPD doi: 10.17816/OV321819

[35] Dalby M, Kristianslund O, Østern AE, et al. Longitudinal corneal endothelial cell loss after corrective surgery for late in-the-bag IOL dislocation: a randomized clinical trial. J Cataract Refract Surg. 2020;46(7):1030–1036. doi: 10.1097/j.jcrs.0000000000000213

[36] Dalby M., Kristianslund O., Østern A.E., et al. Longitudinal corneal endothelial cell loss after corrective surgery for late in-the-bag IOL dislocation: a randomized clinical trial // J Cataract Refract Surg. 2020. Vol. 46, N 7. P. 1030–1036. doi: 10.1097/j.jcrs.0000000000000213

[37] Armonaite L, Löfgren S, Behndig A. Iris suture fixation of out-of-the-bag dislocated three-piece intraocular lenses. Acta Ophthalmol. 2019;97(6):583–588. doi: 10.1111/aos.14059

[38] Armonaite L., Löfgren S., Behndig A. Iris suture fixation of out-of-the-bag dislocated three-piece intraocular lenses // Acta Ophthalmol. 2019. Vol. 97, N 6. P. 583–588. doi: 10.1111/aos.14059

[39] Galvis V, Villamil JF, Acuña MF, et al. Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®). Graefes Arch Clin Exp Ophthalmol. 2019;257(12):2775–2787. doi: 10.1007/s00417-019-04506-9

[40] Galvis V., Villamil J.F., Acuña M.F., et al. Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®) // Graefes Arch Clin Exp Ophthalmol. 2019. Vol. 257, N 12. P. 2775–2787. doi: 10.1007/s00417-019-04506-9

[41] Kaplowitz K, Yung E, Flynn R, Flynn R. Current concepts in the treatment of vitreous block, also known as aqueous misdirection. Surv Ophthalmol. 2015;60(3):229–241. doi: 10.1016/j.survophthal.2014.12.004

[42] Kaplowitz K., Yung E., Flynn R., Flynn R. Current concepts in the treatment of vitreous block, also known as aqueous misdirection // Surv Ophthalmol. 2015. Vol. 60, N 3. P. 229–241. doi: 10.1016/j.survophthal.2014.12.004

RIGHTS & PERMISSIONS

Eco-Vector